Approval · Notice of Compliance 5472 · 1994
TAZOCIN: Notice of Compliance 5472
Issued September 13, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5472
- Date
- September 13, 1994
- Company
- Lederle Cyanamid Canada Inc.St-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Antibiotic, B-lactamase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TAZOCIN | Not yet assigned | — |
Medicinal ingredients
- TAZOBACTAM SODIUM 0.5 G per VIAL
- PIPERACILLIN SODIUM 4 G per VIAL
- TAZOBACTAM SODIUM 0.25 G per VIAL
- PIPERACILLIN SODIUM 2 G per VIAL
- TAZOBACTAM SODIUM 0.375 G per VIAL
- PIPERACILLIN SODIUM 3 G per VIAL